CRWE Select

CRWESelect Announces MPPC, CRXX, PWRM, HCEI,JVA

_______________________________

myPhotopipe.com, Inc. (Pink Sheets: MPPC) a web-based online provider of professional digital photo processing, photo finishing, photo sharing, and related services, today announced record sales for November 2009, when compared with the prior-year period, reflecting explosive growth in digital camera sales and the increasing popularity of processing photos online rather than at retail kiosks.

myPhotopipe.com, Inc. (Pink Sheets: MPPC) today announced final plans to enter the model and fashion industry with a new online website called mymodelcomps.com.

Model comps, also known as model composites, are used by virtually all fashion models, along with aspiring actors and actresses, to present themselves to directors, stylists and modeling agencies. A typical comp is a two-sided sheet with a number of photographs on one side and relevant information on the other. Model comps are like resumes and are used nationwide. “This is an enormous segment of the digital photo industry, one that absolutely relies on a quality product,” stated Robert Quick, Chief Executive Officer of myPhotopipe.com, Inc. “If you look bad on your model comp, you won’t get the job. So a quality model comp makes a critically important impression. We are experts in delivering superb quality in digital photographs. Our products will provide models with a competitive edge by making them look great.”

About myPhotopipe.com, Inc.

myPhotopipe.com, Inc. is a web-based online provider of digital photo processing, photo finishing, photo sharing, and related services. The Company’s unique blend of 1000 print options, combined with manual print inspections and professional color management, have positioned myPhotopipe.com as one of the fastest-growing providers of digital photography services for professionals and serious amateurs.

The Company is headquartered in Atlanta, Georgia, and its common stock is listed on the OTC Pink Sheets under the symbol “MPPC”. Additional information is available on the Internet at www.myPhotopipe.com.

_______________________________

Stockholders of CombinatoRx and Neuromed Vote for Merger

CombinatoRx, Incorporated (NASDAQ: CRXX) and Neuromed Pharmaceuticals Inc., a privately held biopharmaceutical company, announced today that their respective stockholders approved the merger between CombinatoRx and Neuromed and all other related proposals at each of their stockholder meetings on December 18, 2009. CombinatoRx and Neuromed expect the merger will close on Monday, December 21, 2009.

About CombinatoRx

CombinatoRx, Incorporated (CRXX) is pioneering the new field of synergistic combination pharmaceuticals. Going beyond traditional combinations, CombinatoRx creates product candidates with novel mechanisms of action, striking at the biological complexities of human disease. The CombinatoRx proprietary drug discovery technology provides a renewable and previously untapped source of novel drug candidates. CombinatoRx was founded in 2000 and is located in Cambridge, Massachusetts. To learn more about CombinatoRx, please visit www.combinatorx.com.

About Neuromed

Neuromed is a privately held biopharmaceutical company in business to develop new and improved pain medicines. Neuromed has multiple programs aimed at addressing this important unmet medical need. The rights to its lead product candidate, Exalgo™, designed to be a once-daily, oral hydromorphone treatment, seeking FDA approval for chronic to severe pain, were recently acquired by Mallinckrodt Inc., a subsidiary of Covidien plc. Neuromed is also developing oral drug candidates to block N-type and T-type calcium channels, important targets directly involved in pain signaling, and includes candidates for potentially treating pain, epilepsy and hypertension. For more information, visit Neuromed’s website at www.neuromed.com.

______________________________________

PWRM, Power 3 Medical Products Inc, PWRM.OB

PWRM is a leading bio-medical company engaged in the commercialization of neurodegenerative disease and cancer biomarkers, pathways, and mechanisms of diseases through the development of diagnostic tests and drug targets. PWRM’s patent-pending technologies are being used to develop screening and diagnostic tests for the early detection and prognosis of disease, identify protein biomarkers, and drug targets. Diagnostic tests are targeted toward markets with critical unmet needs in areas including neurodegenerative disease (NuroPro(R)) and breast cancer (BC-SeraPro(TM)). PWRM expects to complete phase II clinical validation trials of its blood serum diagnostics for Alzheimer’s disease (NuroPro-AD), Parkinson’s disease (NuroPro-PD) and breast cancer in 2010, followed by filings with the FDA. Power3 operates a state-of-the-art CLIA certified laboratory in The Woodlands (Houston), Texas. Power3 continues to evolve and enhance its IP portfolio, employing sensitive and specific combinations of biomarkers it has discovered from a broad range of diseases as the basis of highly selective blood-based tests for ALS, Alzheimer’s, and Parkinson’s diseases, and breast cancer.

More about PWRM at www.power3medical.com

________________________________________

Healthy Coffee Expands in Europe, Sets Founders Meeting in London, UK and Opens Healthy Coffee Germany

Healthy Coffee International, Inc. (Pinksheets:HCEI) announced that it is expanding its sales in Europe, and will hold a Founders Meeting in London, UK and open Healthy Coffee Germany.

Sorani Mkandawire, VP Healthy Coffee UK, commented: “We are excited to have our Founder & CEO Rick Aguiluz as our guest speaker during our Founders meeting on Dec. 17th at the Holiday Inn in Earl’s Court.”

Bob Gaskell, Director of Network Development, Healthy Coffee UK, added: “We are looking forward to expanding our network, not only in the UK, but in the whole of Europe as well.”

ABOUT HEALTHY COFFEE INTERNATIONAL, INC.

Healthy Coffee International, Inc., category creator of Healthy Coffee, is focused on bringing health to the world’s largest and most popular drink, coffee. The company’s proprietary formulas combine the health benefits of Ginseng, Reishi Mushroom, and other top quality ingredients with the world’s finest coffee beans to create a line of deliciously healthy instant gourmet coffee drinks. Healthy Coffee is well positioned in the market place at the intersection of three mega-billion dollar industries: coffee, wellness and energy drinks, and has quickly established offices in 9 countries and distributors in 29 other countries through its marketing subsidiary Healthy Coffee USA, Inc. (www.HealthyCoffee.com) which uses a simple and unique Internet-driven international business model that allows the average person to own and operate a local, national, or international coffee distribution or coffee house business with very little capital investment or overhead. For more information, visit www.HCEI.biz.

________________________________________

Coffee Holding Co., Inc. (”Coffee Holding”) (AMEX:JVA), a leading integrated wholesale coffee roaster and dealer in the United States, has engaged Liolios Group, Inc. to help lead the company’s new investor relations and financial communications program.

“We have arrived at a pivotal stage in our development that has made it important for a team of experienced professionals like Liolios Group to help us deliver our message more effectively to our shareholders and raise our profile in the investment community,” said Andrew Gordon, president and CEO of Coffee Holding. “Liolios Group not only understands our industry but they also bring a proven record of assisting emerging growth companies in building quality, long-term relationships with investors, analysts, money managers and institutions.”

About Coffee Holding Co., Inc. (AMEX:JVA)

Coffee Holding is a leading integrated wholesale coffee roaster and dealer in the United States and one of the few coffee companies that offers a broad array of coffee products across the entire spectrum of consumer tastes, preferences and price points. The management of Coffee Holding has been in the industry for over 30 years and has remained profitable through varying cycles in the coffee industry and the economy. The company’s private label and branded coffee products are sold throughout the United States, Canada and abroad to supermarkets, wholesalers, and individually owned and multi-unit retail customers. More information can be found at www.coffeeholding.com.

About Liolios Group

Liolios Group, Inc. is a highly selective and comprehensive investor relations firm specializing in small and micro-cap companies. The company aims to deliver superior performance in corporate messaging and positioning, investor awareness, analyst and financial press coverage, and capital attraction. Founded in 1996 in Newport Beach, California, Liolios Group partners each have more than 15 years experience in finance and investments, and have represented more than 120 companies in a wide range of industries. For more information about Liolios Group, go to www.liolios.com.

_______________________________

***********Advertisement***********

Disclaimer: Our disclaimer is to be read and fully understood before using our site, reading our newsletter or joining our email list. Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment (read more) Rule 17B requires disclosure of payment for investor relations. Crown Equity Holdings, Inc. (CRWE.OB) has received five thousand dollars from MyPhotopipe.com Inc. (MPPC.PK) for 30 days of advertisement services.,Crown Equity Holdings, Inc. (CRWE.OB) has previously received five hundred thousand shares compensation for 30 days of advertisement services and has received an additional 1,000,000 shares 144 restricted stocks for 6 months of advertisement and diseminate news and $15,000 dollars for IR services for Power 3 Medical Products Inc. (PWRM.OB).

The views expressed in any article, reports, writings are not necessarily the views of Crown Equity Holdings, Inc. its officers, directors, staff, contractors or employees. They do not represent the views or opinions of this site. Views expressed in articles are those of the author alone.